BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
9.17
-0.58 (-5.90%)
At close: Nov 14, 2025, 4:00 PM EST
9.00
-0.16 (-1.80%)
After-hours: Nov 14, 2025, 6:14 PM EST
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $18.49 million as of November 14, 2025. Its market cap has decreased by -38.59% in one year.
Market Cap
18.49M
Enterprise Value
300.39K
1-Year Change
-38.59%
Ranking
Category
Stock Price
$9.17
Market Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has decreased from $26.00M to $18.49M, a decrease of -28.90%. That is a compound annual growth rate of -6.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2025 | 18.30M | -26.80% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
| Feb 24, 2021 | 26.00M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 923.53B |
| Johnson & Johnson | 472.75B |
| AbbVie | 413.74B |
| UnitedHealth Group | 292.08B |
| AstraZeneca | 276.17B |
| Novartis AG | 256.16B |
| Merck & Co. | 234.40B |
| Abbott Laboratories | 226.47B |